Quick Summary
Covering the latest research from top Wall Street investment banks

Strong Results and Raised Guidance Reinforce Bullish View; Capacity and Disaggregated Inference Open Incremental Opportunity

Institution
Morgan Stanley
Date
2026-08-13
Authors
Joseph Moore, Shane Brett, Mason Wayne
Company
CEREBRAS SYSTEMS INC
Ticker
CBRS.US
Industry
Semiconductors
Rating
Overweight
BullishHigh confidenceSecond-quarter core revenue, gross margin, and operating margin all exceeded expectations, and full-year guidance was raised; increased capacity commitments, disaggregated inference, and opportunities with hyperscale customers such as AWS provide upside optionality, though capacity delivery and revenue ramp execution remain the key variables.
AuthorsJoseph Moore, Shane Brett, Mason Wayne
Target price$279.00
CoverageUnited States
Business segmentsCore Hardware、Cloud and Other Services、Fast Inference Solutions
Research firm divisions/subsidiariesMorgan Stanley(Other)

AI summary card

Strong Results and Raised Guidance Reinforce Bullish View; Capacity and Disaggregated Inference Open Incremental Opportunity

Morgan Stanley reiterates CBRS Overweight and raises its target price from $273 to $279, believing capacity expansion, fast-inference demand, and onboarding of hyperscale customers can continue to drive earnings higher.

Overweight|Target Price $279.00|Current Price $262.06|Industry View: Attractive
Earnings BeatRaised GuidanceAI InferenceCapacity ExpansionAWSAMDSemiconductors
  • Q2 core revenue was $209.9mn, up 103% year over year and above Morgan Stanley's $194.3mn estimate.
  • The company has secured more than 600MW of operational or contracted capacity through the end of 2027, and Morgan Stanley has raised modeled capacity to approximately 560MW.
  • The disaggregated inference solution works with AMD and AWS Trainium; management believes throughput could increase by up to 5x and may improve unit costs and gross margins.
  • The company expects FY27 core revenue to grow by more than 3x; the Cerebras offering through AWS is expected to become broadly available in Q1 2027.
  • The stock faces near-term pressure from elevated expectations, margin pressure, and August lock-up expirations, but the report sees no concerning change in fundamentals.

Report interpretation

Overview

Cerebras exceeded expectations in Q2 on core revenue, gross margin, and operating margin, and raised its FY26 outlook. Morgan Stanley believes fast-inference demand continues to exceed available compute supply, while the company's wafer-scale processor architecture, expanding cloud capacity, and disaggregated inference partnerships with AMD and AWS support its long-term growth thesis; it maintains its Overweight rating.

Core views

Capacity is the most important near-term operating driver. Data-center availability remains a bottleneck, but more than 600MW of operational or contracted capacity through the end of 2027 improves visibility into the revenue ramp.Disaggregated inference can have GPUs or other accelerators handle prefilling, while Cerebras systems handle decoding; if commercialized successfully, both throughput and unit economics could improve materially.AWS is expected to begin contributing more broadly to hyperscale-customer revenue in 2027, while Morgan Stanley's current model remains conservative on this contribution, creating upside potential.The technology roadmap continues to advance, with CS4 expected to launch shortly and CS5 targeted for the second half of 2027; the ability to serve leading frontier models helps alleviate market concerns about suitability for large-scale workloads.Valuation uses 13x 2028 adjusted revenue, benchmarked against AI semiconductor peers, and the target-price increase mainly reflects higher 2028 revenue expectations.

Analysis framework

The assessment is based on variances between actual quarterly performance and analyst expectations, combined with management guidance, capacity deployment, customer/partner progress, and long-term revenue and margin modeling; valuation uses a revenue-multiple approach based on comparable AI semiconductor companies.

Methodology notes

  • Valuation methodsRevenue Multiple Method

    13x valuation of 2028 adjusted revenue

    Applies a 13x multiple to 2028 adjusted revenue of $6.3bn; this multiple is broadly consistent with small- and mid-cap AI semiconductor companies with high AI revenue exposure and growth rates above the market.

  • Scenario AnalysisBull/Base/Bear Scenarios

    Capacity deployment and hardware demand determine revenue growth and target-price ranges

    The bull case assumes deployment of more than 1GW of capacity by 2028; the bear case assumes capacity delays, lower utilization, and weak hardware demand.

  • Earnings AnalysisActual Results Versus Expectations

    Revenue, gross margin, operating margin, and EPS beats

    Assesses earnings quality and subsequent forecast revisions by comparing actual quarterly metrics and company guidance with Morgan Stanley's prior estimates.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • CBRS.US
    Directly Covered Security
    Strengths
    Strong demand for fast inference; differentiated wafer-scale processor architecture; improved capacity availability; partnerships with AMD and AWS provide commercialization expansion opportunities.
    Weaknesses
    Current profitability remains in a ramp-up phase; business expansion depends on large-scale data-center construction and customer deployment timing.
    Comparison
    Valuation uses a 13x multiple of 2028 adjusted revenue, near the average level for AI semiconductor peers.
    Risks
    Capacity deployment delays, customer concentration, intensifying competition, weaker-than-expected hardware demand, and short-term volatility from lock-up expirations.

Key data

  • Q2 Core Revenue$209.9mnUp 9.7% quarter over quarter and 103% year over year, above Morgan Stanley's $194.3mn estimate.
  • Q2 Core Gross Margin40.6%Approximately 380 basis points above Morgan Stanley's 36.8% estimate.
  • Q2 Non-GAAP EPS-$0.05Better than Morgan Stanley's -$0.21 estimate.
  • Core Cloud and Other Services Revenue$127.7mnUp 287% year over year.
  • Remaining Performance Obligations$25.4bnBalance at quarter-end.
  • September-Quarter Core Revenue Guidance$214mn-$216mnMidpoint of $215mn, up 2.4% quarter over quarter and 58% year over year, above Morgan Stanley's $205.9mn estimate.
  • FY26 Core Revenue Forecast$886mnPreviously $863mn.
  • FY27 Revenue Forecast$2.88bnPreviously $2.71bn.
  • FY28 Revenue Forecast$6.70bnPreviously $6.46bn.
  • FY26 Core Gross Margin Forecast41.8%Previously 39.4%.
  • Secured Capacity>600MWOperational or contracted capacity expected to be delivered through the end of 2027; Morgan Stanley's model is approximately 560MW.
  • Target Price$279.00Raised from $273, based on 13x 2028 adjusted revenue of $6.3bn.

Impact & implications

The report's key implication is that Cerebras's investment thesis is shifting from pure high-growth expectations to three verifiable drivers: capacity delivery, improved inference efficiency, and hyperscale-customer commercialization. If capacity comes online faster than model assumptions, or AWS and disaggregated inference generate scaled revenue earlier, revenue and margin forecasts could see further upside; conversely, valuation is sensitive to execution misses and near-term trading volatility.

Risks

  • Delays in data-center and power-capacity deployment could cause a slower-than-expected revenue ramp and lower utilization.
  • Customer concentration is high, and changes in purchasing cadence by key customers could materially affect performance.
  • Intensifying competition in AI inference and accelerators could pressure pricing, market share, or gross margins.
  • The timing and scale of commercialization for AMD/AWS disaggregated inference and hyperscale-customer partnerships remain uncertain.
  • The company must execute large-scale capacity buildouts amid rapid expansion, with high capital requirements and operating complexity.
  • Staggered lock-up expirations in August could increase short-term share-price volatility.

What to watch

  • Actual delivery, commissioning, and utilization progress for more than 600MW of capacity, and whether it exceeds the approximately 560MW model assumption.
  • Delivery against September-quarter revenue guidance and 38%-40% core gross-margin guidance.
  • Customer adoption, orders, and revenue contribution after the AWS channel becomes broadly available in Q1 2027.
  • Commercialization progress for AMD and AWS Trainium disaggregated inference solutions, including evidence of throughput gains and gross-margin improvement.
  • Order, RPO, and customer-demand validation of the target for more than 3x FY27 core revenue growth.
  • The impact of the CS4 launch and CS5 R&D progress on technology competitiveness and customer deployments.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins